XSAU
4013
Market cap24bUSD
Nov 12, Last price
264.00SAR
Name
Dr Sulaiman Al-Habib Medical Services Group Co
Chart & Performance
P/E
38.48
P/S
6.74
EPS
6.86
Div Yield, %
1.77%
Shrs. gr., 5y
—
Rev. gr., 5y
18.52%
Revenues
13.71b
+22.38%
Net income
2.40b
+3.72%
CFO
3.08b
+3.84%
Dividend
Nov 02, 20251.21 SAR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Riyadh, Saudi Arabia, Dr. Sulaiman Al Habib Medical Services Group Company, established in 1993, specializes in the development, management, and operation of a wide spectrum of healthcare facilities across the Kingdom. Its extensive portfolio encompasses general and specialized hospitals, various medical complexes, outpatient surgical centers, and pharmaceutical facilities. The group operates hospitals focusing on specific areas such as maternity services, orthopedics, and spinal surgeries. Furthermore, it oversees specialized clinics for dermatology, plastic surgery, ophthalmology, obesity treatment, and fertility, complemented by its network of pharmacies. Beyond direct patient care, the company provides home medical services, advanced laboratory diagnostics, technology and information system support, facility upkeep, medical equipment maintenance, and telemedicine solutions.
Valuation
Title SAR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||